The Research and Development Team at HCW Biologics focuses on advancing innovative immunotherapy candidates by conducting in-depth research and optimizing downstream processes. Collaborating across various specialties, the team evaluates the efficacy of candidates targeting chronic inflammation through inflammasome modulation and senescent cell clearance, ensuring the efficient development and scalability of successful therapies.
View all